Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

被引:6
|
作者
Siddi, Sara [1 ,2 ]
Gine-Vazquez, Iago [1 ,2 ]
Bailon, Raquel [3 ,4 ]
Matcham, Faith [5 ,6 ]
Lamers, Femke [7 ,8 ]
Kontaxis, Spyridon [3 ,4 ]
Laporta, Estela [4 ]
Garcia, Esther [4 ,9 ]
Arranz, Belen [1 ,2 ]
Dalla Costa, Gloria [10 ]
Guerrero, Ana Isabel [11 ]
Zabalza, Ana [11 ]
Buron, Mathias Due [12 ]
Comi, Giancarlo [10 ,13 ]
Leocani, Letizia [10 ,14 ]
Annas, Peter [15 ]
Hotopf, Matthew [5 ]
Penninx, Brenda W. J. H. [7 ,8 ]
Magyari, Melinda [12 ]
Sorensen, Per S.
Montalban, Xavier [11 ]
Lavelle, Grace [5 ]
Ivan, Alina [5 ]
Oetzmann, Carolin [5 ]
White, Katie M. [5 ]
Difrancesco, Sonia [7 ]
Locatelli, Patrick [16 ]
Mohr, David C. [17 ]
Aguilo, Jordi [4 ,9 ]
Narayan, Vaibhav [18 ]
Folarin, Amos [5 ]
Dobson, Richard J. B. [5 ]
Dineley, Judith [5 ]
Leightley, Daniel [5 ]
Cummins, Nicholas [5 ]
Vairavan, Srinivasan [18 ]
Ranjan, Yathart [5 ]
Rashid, Zulqarnain [5 ]
Rintala, Aki [19 ,20 ]
De Girolamo, Giovanni [21 ]
Preti, Antonio [22 ]
Simblett, Sara [5 ]
Wykes, Til [5 ]
Myin-Germeys, Inez [19 ]
Haro, Josep Maria [1 ,2 ]
机构
[1] Parc Sanitari St Joan de Deu, Fundacio St Joan de Deu, CIBERSAM, Madrid 28029, Spain
[2] Univ Barcelona, Barcelona 08007, Spain
[3] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza 50001, Spain
[4] Ctr Invest Biomed Red Area Bioingn Biomat & Nanom, Madrid 28029, Spain
[5] Kings Coll London, Inst Psychiat, Psychol & Neurosci, London SE5 8AF, England
[6] Univ Sussex, Sch Psychol, Falmer BN1 9QH, England
[7] Vrije Univ, Dept Psychiat, Amsterdam UMC, NL-1081 HV Amsterdam, Netherlands
[8] Amsterdam Publ Hlth Res Inst, Mental Hlth Program, NL-1081 BT Amsterdam, Netherlands
[9] Univ Autonoma Barcelona, Microelect & Sistemas Elect, Bellaterra 08193, Spain
[10] Univ Vita Salute San Raffaele, Fac Med, I-20132 Milan, Italy
[11] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca,Dept Neurol Neuroimmuno, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona 08035, Spain
[12] Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Rigshosp, DK-2100 Copenhagen, Denmark
[13] Casa Cura Policlin, I-20144 Milan, Italy
[14] Sci Inst San Raffaele, Inst Expt Neurol, Expt Neurophysiol Unit, INSPE, I-20132 Milan, Italy
[15] H Lundbeck & Co AS, DK-2500 Valby, Denmark
[16] Univ Bergamo, Dept Engn & Appl Sci, I-24129 Bergamo, Italy
[17] Northwestern Univ, Ctr Behav Intervent Technol, Dept Preventat Med, Chicago, IL 60611 USA
[18] Janssen Res & Dev LLC, Res & Dev Informat Technol, Titusville, NJ 08560 USA
[19] Katholieke Univ Leuven, Ctr Contextual Psychiat, Dept Neurosci, B-7001 Leuven, Belgium
[20] LAB Univ Appl Sci, Fac Social Serv & Hlth Care, Lahti 15210, Finland
[21] IRCCS Inst Ctr San Giovanni Dio Fatebenefratelli, I-25125 Brescia, Italy
[22] Univ Torino, Dipartimento Neurosci, I-10126 Turin, Italy
关键词
COVID-19; SARS-CoV-2; major depressive disorder; multiple sclerosis; depression severity; heart rate; stress; social activity; physical activity; decentralized; HEART-RATE-VARIABILITY; STRESSFUL LIFE EVENTS; MENTAL-HEALTH; SEDENTARY BEHAVIOR; IMPACT; METAANALYSIS; ASSOCIATION; VALIDITY; ANXIETY; RISK;
D O I
10.3390/jcm11237163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Changes in lifestyle, finances and work status during COVID-19 lockdowns may have led to biopsychosocial changes in people with pre-existing vulnerabilities such as Major Depressive Disorders (MDDs) and Multiple Sclerosis (MS). Methods: Data were collected as a part of the RADAR-CNS (Remote Assessment of Disease and Relapse-Central Nervous System) program. We analyzed the following data from long-term participants in a decentralized multinational study: symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state, steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender. Results: Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall, depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods. Conclusions: Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Impact of COVID-19 pandemic on major depressive disorder in acute psychiatric inpatients
    Brasso, Claudio
    Cisotto, Marta
    Del Favero, Elisa
    Giordano, Benedetta
    Villari, Vincenzo
    Rocca, Paola
    FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [32] Impact of COVID-19 lockdown on a population of progressive multiple sclerosis patients in Northern Italy
    Bosa, C.
    Schillaci, V.
    Alteno, A.
    Marasciulo, S.
    Gemme, L.
    Novelli, R.
    Grosso, L.
    Cavalla, P.
    Vercellino, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 205 - 206
  • [33] Post COVID-19 Major Depressive Disorder and Depersonalization-Derealization Disorder Treated With ECT
    Damiani, Christopher John
    Meyer, Justin Patrick
    Warren-Faricy, Lauren
    JOURNAL OF ECT, 2024, 40 (03) : e15 - e16
  • [34] COVID-19 and lockdown in patients with multiple sclerosis: a descriptive study of prevalence and emotional impact
    Higueras, Y.
    Meldana-Rivera, A.
    Garcia-Dominguez, J. M.
    Goicochea Briceno, H.
    Cuello, J. P.
    Lozano-Ros, A.
    Martinez-Gines, M. L.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 54 - 54
  • [35] CONFISEP: Impact of the Covid-19 pandemic lockdown on patients with multiple sclerosis in the north of France
    Donze, C.
    Massot, C.
    Kwiatkowski, A.
    Guenot, M.
    Hautecoeur, P.
    REVUE NEUROLOGIQUE, 2022, 178 (1-2) : 151 - 155
  • [36] Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
    Bonavita, Simona
    Tedeschi, Gioacchino
    Atreja, Ashish
    Lavorgna, Luigi
    NEUROLOGICAL SCIENCES, 2020, 41 (05) : 1007 - 1009
  • [37] Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab
    Habek, Mario
    Piskac, Dominik
    Gabelic, Tereza
    Barun, Barbara
    Adamec, Ivan
    Skoric, Magdalena Krbot
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
  • [38] Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank
    Hassan, Lamiece
    Peek, Niels
    Lovell, Karina
    Carvalho, Andre F.
    Solmi, Marco
    Stubbs, Brendon
    Firth, Joseph
    MOLECULAR PSYCHIATRY, 2022, 27 (02) : 1248 - 1255
  • [39] Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank
    Lamiece Hassan
    Niels Peek
    Karina Lovell
    Andre F. Carvalho
    Marco Solmi
    Brendon Stubbs
    Joseph Firth
    Molecular Psychiatry, 2022, 27 : 1248 - 1255
  • [40] The effect of COVID-19 pandemic on treatment adherence of people with multiple sclerosis
    Yetkin, M. F.
    Akcakoyunlu, M.
    Mirza, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 57 - 57